NEW YORK (360Dx) – Ceres Nanosciences said today that with Tasso, George Mason University, and the United States Army Medical Research Institute of Infectious Diseases, it has received $4.25 million from the US Department of Defense's Defense Threat Reduction Agency (DTRA) to develop a platform for surveillance of infectious disease outbreaks.

The award is part of a larger, multi-year $11.7 million program funded by the DTRA through which Ceres will work to integrate its Nanotrap enrichment technology with Tasso's HemoLink blood sampling device.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.